Honeywell International’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-207,500
Closed -$13M 96
2018
Q4
$13M Buy
207,500
+800
+0.4% +$55.9K 0.86% 42
2018
Q3
$16M Buy
206,700
+51,700
+33% +$3.9M 0.91% 39
2018
Q2
$11M Buy
+155,000
New +$10.9M 0.66% 63
2015
Q4
Sell
-236,400
Closed -$23.2M 202
2015
Q3
$23.2M Sell
236,400
-96,300
-29% -$10.7M 0.63% 66
2015
Q2
$39M Sell
332,700
-20,900
-6% -$2.28M 0.95% 30
2015
Q1
$34.7M Buy
353,600
+28,600
+9% +$2.9M 0.82% 39
2014
Q4
$30.6M Buy
+325,000
New +$33.6M 0.7% 56

Other funds holding GILD

Honeywell International's GILD Position: Q1 2019 in Review

Honeywell International sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 207,500 shares — an estimated $13M sold.

Honeywell International first reported a position in GILD in Q4 2014 and held it in 7 quarters. The position peaked at $39M in Q2 2015. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Honeywell International reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Honeywell International sold 207,500 Gilead Sciences shares in Q1 2019, an estimated $13M.
  • Honeywell International first reported a position in Gilead Sciences in Q4 2014 and held it in 7 quarters.
  • Honeywell International's Gilead Sciences position peaked at $39M in Q2 2015.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Honeywell International's 13F filing for Q1 2019, filed 2 May 2019.